packageBelzutifan

belzutifan

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Belzutifan is an anticancer medicine used to treat von Hippel-Lindau disease, including kidney cancer associated with it. It is authorised in the European Union and is also under investigation for other uses.

Summary written by glm-5.3-flash from Wikidata Q27456641 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:belzutifan
ATC codes:L01XX74
DrugBank:DB15463
PubChem CID:117947097
Wikidata:Q27456641
formula:C17H12F3NO4S
molar mass:383.34 g/mol (PubChem CID 117947097)
logP:2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown